Applications of 1,3-Dimethyl-5-Phenylbarbituric Acid in Industrial Manufacturing

As the original manufacturer specializing in barbituric acid derivatives, we supply 1,3-Dimethyl-5-Phenylbarbituric Acid predominantly to downstream sectors engaged in fine organic synthesis, pharmaceutical intermediates, dye formulation, and analytical chemistry applications. Each usage scenario detailed below outlines practical industry context, regulatory compliance, manufacturing integration, and representative finished goods.

1. Active Pharmaceutical Ingredient (API) Intermediate for Anticonvulsant Agents

Pharmaceutical manufacturers utilize this compound as an advanced intermediate during the multi-step synthesis of complex barbiturate-class APIs, especially those formulated for central nervous system (CNS) therapies. Facilities must maintain stringent documentation, ingredient traceability, and process validation as required in regulated drug synthesis. Precise dosage control is critical; transfer and reaction volumes are determined according to the targeted yield of the barbiturate nucleus in the API structure, with usage calculated by molar equivalence in the batch protocol.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
• EU GMP Annex 8: Sampling of Starting and Packaging Materials
• Pharmacopoeia monographs (USP, Ph. Eur.) for specific APIs
• FDA 21 CFR Part 210/211 for finished drug manufacturing

Typical usage ratio

• 0.8–1.2 molar equivalents per target API molecule; actual ratio tailored to process yield and loss compensation

Downstream process integration

• Charged during stage 2–5 of barbiturate API synthesis, typically after alkylation or condensation, and purified using phase-specific extraction prior to final API crystallization

Final product types

• Pharmaceutical grade anticonvulsant tablets (e.g., phenobarbital derivatives)
• Barbiturate injectable solutions for clinical hospital use
• Premix granules for oral barbiturate suspension preparations

2. Intermediate for Dye and Pigment Synthesis

The pigment and dye sector incorporates this material as an essential scaffold in synthesizing specialty colorants, particularly those requiring precise aromatic substitution for performance coatings or textile dyes. Color chemists dose exact stoichiometric amounts based on batch mass and coloration intensity targets, with the compound introduced at controlled temperatures to support selectivity and stability of the final shade under high-throughput or continuous processes.

Industry compliance standards

• ISO 9001:2015 Quality Management (dye and pigment manufacturing)
• Oeko-Tex Standard 100 (for textile applications)
• EU REACH Regulation (EC 1907/2006)
• GHS/CLP labeling for workplace chemical safety

Typical usage ratio

• 5–15% by weight relative to the total pigment precursor mix, depending on depth of color and specific dye formulation

Downstream process integration

• Added at the nucleation or ring-closure step during pigment formation, followed by purification, filtration, and blending for standardized color output

Final product types

• Aromatic azo and anthraquinone dyes for synthetic fibers
• High-stability pigment dispersions for automotive coatings
• Precision printing inks for industrial packaging

3. Reagent in Analytical Chemistry

Laboratory supply and specialty reagent firms procure this compound for deployment as a derivatization agent or complexing reagent in qualitative and quantitative analysis protocols. Usage protocols adhere to industry-standard reference methods, and the dosage aligns with test sensitivity—analysts prepare standard solutions where concentration ratios correspond to the detection range or quantification limits of the target analyte.

Industry compliance standards

• ISO/IEC 17025:2017 Testing and Calibration Laboratories
• AOAC official methods (for food and pharmaceutical testing)
• GLP (Good Laboratory Practice) Principles

Typical usage ratio

• 0.01–0.1% (w/v) in aqueous or organic test solution; titrated according to instrument sensitivity and matrix complexity

Downstream process integration

• Prepared as a standard or working solution prior to sample injection in HPLC, UV-Vis, or colorimetric analysis; introduced pre-test as derivatizing reagent

Final product types

• Standard reagent kits for laboratory analysis
• Certified reference materials for pharmaceutical QA/QC
• Color-based analytical test strips

4. Building Block in Fine Organic Synthesis

Custom synthesis operations and contract development manufacturers (CDMOs) utilize the compound as a privileged structure for expanding molecular libraries, especially when developing new heterocyclic chemotypes for research or lead optimization in medicinal or agrochemical research. Formulators adjust the feed ratio in parallel with the reactivity of coupling or cyclization partners, ensuring maximal throughput in multi-step organic reactions.

Industry compliance standards

• ISO 9001:2015 (R&D chemicals manufacturing)
• OECD Principles of Good Laboratory Practice (for regulated sectors)
• Documentation under Controlled Substances Precursor regulations where required

Typical usage ratio

• 5–25 mol% in combinatorial chemistry or as dictated by target molecule design; titrated based on predicted yield and structural complexity

Downstream process integration

• Dosed at the initial condensation or ring-closure phase in automated or manual synthesis reactors; product isolated via chromatographic separation prior to further derivatization

Final product types

• NCE (new chemical entity) candidates for pharmaceutical R&D
• Bioactive molecular building blocks for agrochemical pipeline research
• Intermediates for specialty material science applications